Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy

Inclusion Criteria: * Aged 18 years or more with laboratory evidence of HIV-1 infection and have been on HAART therapy for at least 1 (one) year. * Not to have AIDS (CD4 count \< 250) or AIDS-defining illness. * Bilateral lipoatrophy corresponding to a visual grade 2 or above in the attached Carruthers Lipoatrophy Severity Scale (CLSS). * Available and willing to attend study follow-up visits. * Able and willing to give informed consent. Exclusion Criteria: * Any active skin inflammation or infection in or near the treatment area. * Hypersensitivity to the components of Voluma. * Previous treatment with Voluma or any other product for facial lipoatrophy within the past year. * Has known bleeding disorder * History of keloid formation * Currently receiving systemic corticosteroids or anabolic steroids * Currently on known anticoagulants (i.e. aspirin, non-steroidal anti-inflammatory drugs) * Pregnancy or breastfeeding or anticipating becoming pregnant during the study period. * Any other excluding factors that, according to the investigator's judgment, would preclude enrollment in the study. * Any condition that may interfere with ability to comply with study requirements.